Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.3%

1 terminated out of 19 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

32%

6 trials in Phase 3/4

Results Transparency

30%

3 of 10 completed with results

Key Signals

3 with results91% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (4)
P 2 (5)
P 3 (2)
P 4 (4)

Trial Status

Completed10
Unknown4
Recruiting3
Terminated1
Not Yet Recruiting1

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT03929224Phase 4CompletedPrimary

The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown

NCT03637400Phase 2Completed

Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment

NCT05226260Not ApplicableCompleted

Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care

NCT04278404Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT05899140Phase 4RecruitingPrimary

Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial

NCT04615065Recruiting

Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine

NCT06247761Not ApplicableUnknown

STASSH - TRAUMA - Absorbable vs Non-Absorbable Sutures in Trauma Hand Surgery

NCT06170983Not ApplicableNot Yet RecruitingPrimary

Skin Inflammation and PK of Azithromycin

NCT06149117Phase 4Completed

Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China

NCT06087809Not ApplicableCompleted

Improving Short Course Treatment for Common Pediatric Infections

NCT05880069Unknown

Clinical Outcomes in Patients With Infection by Resistant Microorganism

NCT04239521Completed

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

NCT03372941Phase 4TerminatedPrimary

Hospital Avoidance Strategies for ABSSSI

NCT01593761Phase 2CompletedPrimary

Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus

NCT05339802Phase 2UnknownPrimary

A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections

NCT02052388Phase 2CompletedPrimary

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

NCT00619710Phase 3CompletedPrimary

Complicated Skin and Skin Structure Infections

NCT03131843Phase 3UnknownPrimary

Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination

NCT02512614Phase 2Completed

Evaluation of Novel Antimicrobial Hand Towels

Showing all 19 trials

Research Network

Activity Timeline